Publikationen hier und auf Wunsch     

publications below and on demand                     

Veröffentlichte Ergebnisse    published results

ALPORT EARLY PROTECT Studie

https://www.sciencedirect.com/science/article/pii/S0085253820300260?via%3Dihub 

Europäisches ALPORT Therapieregister   

European ALPORT therapy registry

Pub Med Artikel        articles listed on Pub Med

https://pubmed.ncbi.nlm.nih.gov/32299679/

Clinical Trial Kidney Int . 2020 Jun;97(6):1275-1286.doi: 10.1016/j.kint.2019.12.015.   Epub 2020 Jan 17.

A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome

https://pubmed.ncbi.nlm.nih.gov/33040356/

Clin Genet . 2021 Jan;99(1):143-156.doi: 10.1111/cge.13861.   Epub 2020 Oct 25.

Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trial

https://pubmed.ncbi.nlm.nih.gov/36117978/

Front Med (Lausanne)  2022 Aug 31;9:957733.doi: 10.3389/fmed.2022.957733.   eCollection 2022.

The multifaceted phenotypic and genotypic spectrum of type-IV-collagen-related nephropathy-A human genetics department experience